SBIR/STTR Research Award
DNA Aptamer-3-Fc Conjugates for Treatment of Syphilis
Award amount
$299,868Program and phase
SBIR · Phase IAward year
2025Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NANOHMICS INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- K39ENMXNLA73
- Solicitation number
- PHS 2024-1
- Topic code
- 134
Research abstract
To support the development of an alternative treatment for Syphilis.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- In-situ Multispectral Array Pixelation for Quantum Dot Scene Projectors
- Meta-optic Spectropolarimeter For Heliophysics Imaging
- High Efficiency, Modular T-form Space Refrigeration
- Catalytic Aptazymes for Robust OP Nerve Agent Protection
- Inversely-designed dispersion-engineered electrically small antennas
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Combinations of Oral Antibiotics to Treat Syphilis
- SBIR Topic 134: Alternatives to Benzathine Penicillin for Treatment of Syphilis
Research funding history
306 SBIR/STTR records share this UEI (2003–2025). Reported award amounts total $109,302,435. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Energy, Department of Health and Human Services, Department of Homeland Security, Department of Agriculture